Estimation of the Various Urinary Biomarkers among the Non-Hypertensive Type 2 Diabetic Patients with Nephropathy
Introduction: Alteration in the various markers is seen in diabetic nephropathy (DN). In the current research, four different markers were evaluated and were examined for their diagnostic value in the nephropathic type 2 diabetes patients. Methods: A prospective clinical trial was piloted with diabe...
Main Authors: | Sudarshan Chakraborty, Shigil M Varghese, Sanjay Gabhale, Ankit Shah, Chapala Shashank, Smit Thakkar |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2024-01-01
|
Series: | Journal of Pharmacy and Bioallied Sciences |
Subjects: | |
Online Access: | http://www.jpbsonline.org/article.asp?issn=0975-7406;year=2024;volume=16;issue=5;spage=286;epage=289;aulast=Chakraborty |
Similar Items
-
Comparative diagnostic utility of different urinary biomarkers during pre-albuminuric stages of non-hypertensive type 2 diabetic nephropathy
by: Himansu Sekhar Mahapatra, et al.
Published: (2022-01-01) -
Urinary Retinol Binding Protein (RBP) Level as an early Biomarker of Diabetic Nephropathy in type 2 Diabetic Patients
by: Nilly Abdallah, et al.
Published: (2020-06-01) -
Urinary megalin levels in patients with type 2 diabetic nephropathy and its correlation with renal function
by: Sudharshan Jagennath, et al.
Published: (2024-01-01) -
Urinary angiotensinogen level is correlated with blood pressure level and proteinuria in patients with masked hypertension
by: Ozlem Tiryaki, et al.
Published: (2018-10-01) -
NGAL (Neutrophil Gelatinase-Associated Lipocalin) as an early biomarker of nephropathy in patients with type 2 diabetes
by: Magdy Helmy Zikry Megallaa, et al.
Published: (2023-12-01)